84
Views
60
CrossRef citations to date
0
Altmetric
Review

Clinical aspects, diagnosis and treatment of trichinellosis

, &
Pages 471-482 | Published online: 10 Jan 2014

References

  • Pozio E. New patterns of 711chinella infections. Vet. Parasital 98,133–148 (2001).
  • Murrell KD, Pozio E. Trichinellosis: the zoonosis that won't go quietly. Int. J. Parasital 30,1339–1349 (2000).
  • •A comprehensive review of epidemiology.
  • Pozio E, Foggin CM, Marucci G, et al Trichinella zimbabwensisn.sp. (Nematoda), a new non-encapsulated species from crocodiles (Cmcodylus niloticus) in Zimbabwe also infecting mammals. int. Parasitol 32, 1787–1799 (2002).
  • Dupouy-Carnet J. Trichinellosis: a worldwide zoonosis. Vet. Parasital 93, 191–200 (2000).
  • Pozio E, Marucci G. 711chinella infected pork products: a dangerous gift. Trends Parasital 19,338 (2003).
  • Djordjevic M, Bacic M, Petricevic M, et al Social, political and economic factors responsible for the reemergence of trichinellosis in Serbia: a case study. J. Parasital 89,226–231 (2003).
  • Miliods MD, Bier JW (Ed.), Marcel Dekker, Inc., NY, USA 637–658 (2003).
  • Campbell WC (Ed.), Plenum Press, NY, USA 75–151 (1983).
  • Palmer SR, Lord Soulsby, Simpson DIH (Ed.), Oxford University Press, Oxford, UK 789–802 (1998).
  • Tsieh Sun (Ed.), CRC Press, FL, USA, 117–150 (1994).
  • •A comprehensive review of clinical
  • Capo V, Despommier D. Clinical aspects of infection with Trichinella spp. Clin. Nlicrobial Rev 9,47–54 (1996).
  • Kocicka W Trichinellosis: human disease, diagnosis and treatment. Vet. Parasital 93, 365–383 (2000).
  • Ferraccioli GF, Mercadanti M, Salaffi F, Bruschi F, Melissari M, Pozio E. Prospective rheumatological study of muscle and joint symptoms during Trichineliane/soniinfection. QIM69, 973–984 (1988).
  • •A study of myositis and eosinophilia during the course of trichinellosis.
  • Ozeretskovskaya NN. Pathogenesis, pathomorphology and clinics oftrichinellosis. In: Trichinella and Boyev SN, Bondareva VI, Sokolova TB (Ed.). Kasalch SSR, Scientific Academy, Russia 165–213 (1978).
  • Tanner CE, Martinez Fernandez A, Bolas-Fernandez F (Eds), Consejo Superior de Investigationes Cientificas Press, Madrid, Spain 334–336 (1989).
  • Bessoudo R, Marrie TJ, Smith ER. Cardiac involvement in trichinosis. Chest 79, 698–699 (1981).
  • Compton SJ, Celum CL, Lee C, et al Trichinosis with ventilatory failure and persistent myocarditis. Clin. Infect. Dis. 16, 500–504 (1993).
  • Kassur B, Januszkiewicz J, Poznaska H. Clinical aspects of trichinellosis. In: Tilchinellosis. Kim WC, Pawlowski ZS (Eds). University Press of New England, NH, USA 27–44 (1978).
  • Fourestié V, Douceron H, Brugieres P, Ancelle T, Lejonc JL, Gherardi RK. Neurotrichinosis. A cerebrovascular disease associated with myocardial injury and hypereosinophilia. Brain 116, 603–616 (1993).
  • •A comprehensive review on complications of trichinellosis.
  • Ellrodt A, Halfon P, Le Bras P, et al Multifocal central nervous system lesions in three patients with trichinosis. Arch. Neural 44,432–434 (1987).
  • Ryczak M, Sorber WA, Kandora TF, Camp CJ, Rose FB. Difficulties in diagnosing Trichinella encephalitis. Am. Trop. Med Hyg. 36,573–575 (1987).
  • Taratuto AL, Venturiello SM. Trichinosis. Brain Pathol 7,663–672 (1997).
  • Kociecka W, Gabryel P, Leszyk A, Gustowska L. A case of fatal trichinellosis with early renal insufficiency and central nervous system involvement. Mad. Parazytal 33(4), 545— 551 (1987).
  • Bourée P, Bouvier JP, Passeron J, Galanaud P, Dormont J. Outbreak of trichinosis near Paris. Br. Med. J. 1, 1047–1049 (1979).
  • Campbell WC (Ed.), Plenum Press, NY, USA 367–401 (1983).
  • Dupouy-Camet J, Ancelle T, Fourestié V, Boireau P, Soule C. Trichinelloses. In: Maladies Infectieuses. Encycl Med. Chir. Elsevier; Paris, France 8-517—A-10 (1998).
  • Viallet J, Maclean JD, Goresky LA, Staudt M, Gaetane R, Law C. Arctic trichinosis presenting as prolonged diarrhea. Gastroenterology 91,938–946 (1986).
  • MacLean JP, Viallet J, Law C, Stuart M. Trichinosis in the Canadian Arctic: report of five outbreaks and a new clinical syndrome. J. Infect. Dis. 160, 513–520 (1989).
  • Dupouy-Camet J, Kociecka W, Bruschi F, Bolas-Fernandez F, Pozio E. Opinion on the diagnosis and treatment of human trichinellosis. Expert Opin. Pharmacother. 3,1117–1130 (2002).
  • •A good comprehensive review of diagnosis and treatment of trichinellosis.
  • Pielok L. Clinical analysis and evaluation of selected laboratory parameters in patients examined in distant periods after trichinellosis. Mad. Parazytal 47, 185–209 (2001).
  • Harms G, Binz P, Feldmeier H, et al. Trichinosis: a prospective controlled study of patients 10 years after acute infection. Clin. Infect. Dis. 17,637–643 (1993).
  • Froscher W, Gullotta F, Saathoff M, Tackmann W Chronic trichinosis. Clinical, bioptic, serological and electromyographic observations. Eur. Neural. 28,221–226 (1988).
  • Doby JM, Couatarmanac'h A, Campion JP, Beurton D, Gendre B. Trichinose humaine et immunodépression. Un cas chez un greffé renal. Med. Malad. Infect. 14,293–298 (1984).
  • Pozio E, Doby JM, La Rosa G, Rossi P, Bruschi F. Identification biochimique de l'agent etiologique d'une trichinellose asymptomatique observee chez un sujet immunodeprime en France. Bull. Soc. Francaise Parasite'. 7,201–208 (1989).
  • Louthrenoo W, Mahanuphab P, Sanguanmitra P, Thamprasert K. Trichinosis mimicking polymyositis in a patient with human immunodeficiency virus infection. Br. J. RheumateL 32, 1025–1026 (1993).
  • Jacobson ES, Jacobson HG. Trichinosis in an immunosuppressed human host. Am. J. Clin. PathoL 68,791–794 (1977).
  • Pozio E, Varese P, Gomez-Morales MA, Croppo GP, Pelliccia D, Bruschi F. Comparison of human trichinellosis caused by Trichinella spiralis and by Trichinella britovi. Am. J. Trop. Med Hyg. 48,568-575 (1993).
  • Jongwutiwes S, Chantachum N, Kraivichian P, et al First outbreak of human trichinellosis caused by Trichinella pseudospiralis. Clin. Infect. Dis. 26, 111–115 (1998).
  • Ranque S, Faugere B, Pozio E, et al Trichinella pseudespiralis outbreak in France. Emerg Infect Dis. 6,543–547 (2000).
  • Owen IL, Pozio E, Tamburrini A, Danaya RT, Bruschi F, Gomez Morales MA. Focus of human trichinellosis in Papua New Guinea. Am. J. 7i-op. Med. Hyg. 65, 553–557 (2001).
  • Kociecka W, Bombicki K, Pielok A, Gustowska L. New aspects of clinical pathology and electrophysiological muscle disturbances in patients with history of trichinellosis. Parasite 8, S173—S175 (2001).
  • Bruschi F, Tassi C, Pozio E. Parasite-specific antibody response in Trichinella sp. 3 human infection: a 1 year follow-up. Am. 7i-op. Med Hyg. 43,186-193 (1990).
  • Bruschi F, Moretti A, Wassom D, Piergili Fioretti D. The use of a synthetic antigen for the serological diagnosis of human trichinellosis. Parasite 8, S141—S143 (2001).
  • Pozio E, La Rosa G. P CR-derived methods for the identification of Trichinella parasites from animal and human samples. Meth. Mal Biel 216, 299–309 (2003).
  • Marriner SE, Morris DL, Dickson B, Bogan JA. Pharmacokinetics of albendazole in man. Eur. j Clin. PharmaceL 30,705–708 (1986).
  • Ortega-Pierres G, Gamble R, van Knapen F, Wakelin D (Eds), Trichinellosis. Germar Press, Nonoalco Tlateloco, Mexico 635–641 (1996).
  • Levin ML. Treatment of trichinellosis with mebendazole. Am. J. Trop. Med. Hyg. 32,980–983 (1983).
  • Pozio E, Sacchini D, Sacchi L, Tamburrini A, Alberici F. Failure of mebendazole in treating Trichinella spiralis infection in humans at the stage of encapsulating larvae. Clin. Infect. Dis. 32, 638–642 (2001).
  • Kociecka W, Stefaniak J, Kacprazak E, Pakula M. Clinical evaluation of albendazole in the therapy of human trichinellosis. Wiad. ParazyteL 34, 457–466 (1989).
  • Kim CW, Ruitenberg EJ, Teppema JS (Ed.), Reedbooks, Chertsey, UK 287–290 (1980).
  • Watt G, Saisorn S, Jongsakul K, Sakolvaree Y, Chaicumpa W Blinded placebo-controlled trial of antiparasitic drugs for trichinosis myositis. J. Infect. Dis. 182,371–374 (2000).
  • Fourestie V, Bougnoux ME, Ancelle T, et al Randomized trial of albendazole versus thiabendazole plus flubendazole during an outbreak of human trichinellosis. ParasiteL Res. 75,36–41 (1988).
  • •The first randomized trial comparing different anthelmintics in the course of trichinellosis.
  • Horton J. The use of antiprotozoan and anthelmintic drugs during pregnancy and contraindications. J. Infect. 26,104–105 (1993).
  • Auer H, Kollaritsch H, Japtner J, Aspock H. Albendazole and pregnancy. Appl Parasite'. 35,146–147 (1994).
  • Bradley M, Horton J. Assessing the risk of benzimidazole during pregnancy. Trans. Roy. Soc. 71-op. Med Hyg. 95, 72–73 (2001).
  • Gamble HR, Bessonov AS, Cuperlovic K, et al. International Commission on Trichinellosis: recommendations on methods for the control of Trichinella in domestic and wild animals intended for human consumption. Vet. Parasite'. 93, 393–408 (2000).

Websites

  • International Commission on Trichinellosis www.med.unipi.idict/welcome.htm (Viewed 15th August)
  • International Trichinella Reference Center www.trichi.iss.it (Viewed 15th August)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.